Before market open, Biohaven announced that the U.S. Food and Drug Administration (FDA) had accepted its New Drug Application (NDA) for troriluzole. This is a once-daily oral treatment for adults with ...

In a recent virtual meeting, GRI Bio, Inc. (NASDAQ:GRI), a pharmaceutical company whose stock has declined nearly 98% over the past year according to InvestingPro data, received stockholder approval ...

Acumen Pharmaceuticals, Inc. (ABOS) stock has reached a new 52-week low, trading at $1.31 USD, as investors navigate a turbulent market environment. This latest price point reflects a significant ...

Axsome Therapeutics, Inc.'s' stock surges 30% amid key catalysts. Learn why it's now rated a Buy wih upcoming data opportunities. Click for my AXSM update.

Released on Friday, February 7, the January jobs report showed resilience in the labor market with higher-than-expected wage ...

They are important niches to the scientists who can now solve previously unsolvable problems, but they may not constitute ...

This post may contain links from our sponsors and affiliates, and Flywheel Publishing may receive compensation for actions ...

In this piece, we will look at the stocks Jim Cramer recently discussed.

Latin Americans would broadly support the use of US military force to oust Venezuelan strongman Nicolás Maduro and take on ...

Viracta, a California biotech oncology firm, is laying off every remaining employee and shutting down after its cash stores ...

President Donald Trump signed off Monday on expanding the tariffs he placed on steel and aluminum imports during his first term in office.